Evolent Health Inc (EVH)
$11.43 $0.41 (3.70%) 4:37 PM 12/10/24
NYSE | $USD | Health Information ServicesStock Data
-
Market Cap
$1.28B -
Day's Range
$10.90 - $11.54 -
Volume
2,743,778 -
52 Week Low / High
$10.82 - $35.00 -
PE Ratio
- -
PEG Ratio
-1.37 -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 10
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $46.78
- Target Price
Company News
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says — Oct 8th, 2024
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says...
-
High Growth Tech Stocks To Watch In October 2024 — Oct 11th, 2024
The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies t...
-
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week — Oct 3rd, 2024
Evolent Health, Inc. (NYSE:EVH) shareholders have seen the share price descend 17% over the month. But that doesn't change the fact that shareholders have received really good returns over the last five years. It's fair to say most would be happy with 260% the gain in that time. We think i...
-
Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024 — Oct 11th, 2024
Company to Participate in Upcoming Conferences WASHINGTON, Oct. 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, to...
Portfolio
Comprised of 1 portfolios